𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Management of hepatocellular carcinoma: An update

✍ Scribed by Jordi Bruix; Morris Sherman

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
217 KB
Volume
53
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Updated management of hepatocellular car
Updated management of hepatocellular carcinoma
✍ Gin-Ho Lo πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 255 KB πŸ‘ 1 views

We read with great interest the article by Teixera-Clerc et al., 1 regarding the hepatoprotective properties displayed by cannabinoid receptor 2 (CB2) agonists in a mouse model of carbon tetrachloride (CCl 4 )-induced liver injury. Acute hepatitis induced by CCl 4 was accelerated in CB2 knockout mic

Coffee drinking and hepatocellular carci
Coffee drinking and hepatocellular carcinoma: An update
✍ Francesca Bravi; Cristina Bosetti; Alessandra Tavani; Carlo La Vecchia πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 1 views

accurately distinguish them before the determination of therapy (i.e., liver transplantation). Our data show that the application of the American Association for the Study of Liver Diseases guidelines prevents a false-positive diagnosis of ICC in cirrhosis. Small ICC may display an early enhancement

Management of hepatocellular carcinoma
Management of hepatocellular carcinoma
✍ Jordi Bruix; Morris Sherman πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 286 KB
Ecocentric management: an update
Ecocentric management: an update
✍ Miguel Pina e Cunha; ArmΓ©nio Rego; JoΓ£o Vieira da Cunha πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 91 KB
Management of inflammatory carcinoma of
Management of inflammatory carcinoma of breast with combined modality approachβ€”an update
✍ Aman U. Buzdar; Eleanor D. Montague; Jerry L. Barker; Gabriel N. Hortobagyi; Geo πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 454 KB πŸ‘ 1 views

Thirty-two patients with inflammatory breast cancer were treated with a combined modality approach consisting of combination chemotherapy with fluorouracil, doxorubicin hydrochloride, and cyclophosphamide, followed by radiation therapy. The disease-free interval and survival of this group were compa